Back to Search Start Over

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Authors :
Especialidades médico-quirúrgicas
Medikuntza eta kirurgia espezialitateak
Turajlic, Samra
Xu, Hang
Litchfield, Kevin
Rowan, Andrew
Chambers, Tim
López Fernández de Villaverde, José Ignacio
Nicol, David
O'Brien, Tim
Larkin, James
Horswell, Stuart
Stares, Mark
Au, Lewis
Jamal-Hanjani, Mariam
Challacombe, Ben
Chandra, Ashish
Hazell, Steve
Eichler-Jonsson, Claudia
Soultati, Aspasia
Chowdhury, Simon
Rudman, Sarah
Lynch, Joanna
Archana Sinduri, Fernando
Stamp, Gordon
Nye, Emma
Jabbar, Faiz
Spain, Lavinia
Lall, Sharanpreet
Guarch, Rosa
Falzon, Mary
Proctor, Ian
Pickering, Lisa
Gore, Martin E.
Watkins, Thomas B. K.
Ward, Sophia
Stewart, Aengus
DiNatale, Renzo
Becerra, Maria F.
Reznik, Ed
Hsieh, James J.
Richmond, Todd A.
Mayhew, George F.
Hill, Samantha M.
McNally, Catherine D.
Jones, Carol
Rosenbaum, Heidi
Stanislaw, Stacey
Burgess, Daniel L.
Alexander, Nelson R.
Swanton, Charles
Especialidades médico-quirúrgicas
Medikuntza eta kirurgia espezialitateak
Turajlic, Samra
Xu, Hang
Litchfield, Kevin
Rowan, Andrew
Chambers, Tim
López Fernández de Villaverde, José Ignacio
Nicol, David
O'Brien, Tim
Larkin, James
Horswell, Stuart
Stares, Mark
Au, Lewis
Jamal-Hanjani, Mariam
Challacombe, Ben
Chandra, Ashish
Hazell, Steve
Eichler-Jonsson, Claudia
Soultati, Aspasia
Chowdhury, Simon
Rudman, Sarah
Lynch, Joanna
Archana Sinduri, Fernando
Stamp, Gordon
Nye, Emma
Jabbar, Faiz
Spain, Lavinia
Lall, Sharanpreet
Guarch, Rosa
Falzon, Mary
Proctor, Ian
Pickering, Lisa
Gore, Martin E.
Watkins, Thomas B. K.
Ward, Sophia
Stewart, Aengus
DiNatale, Renzo
Becerra, Maria F.
Reznik, Ed
Hsieh, James J.
Richmond, Todd A.
Mayhew, George F.
Hill, Samantha M.
McNally, Catherine D.
Jones, Carol
Rosenbaum, Heidi
Stanislaw, Stacey
Burgess, Daniel L.
Alexander, Nelson R.
Swanton, Charles
Publication Year :
2018

Abstract

Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes that have not been systematically studied to date. Here, we analyzed 575 primary and 335 metastatic biopsies across 100 patients with metastatic ccRCC, including two cases sampledat post-mortem. Metastatic competence was afforded by chromosome complexity, and we identify 9p loss as a highly selected event driving metastasis and ccRCC-related mortality (p = 0.0014). Distinct patterns of metastatic dissemination were observed, including rapid progression to multiple tissue sites seeded by primary tumors of monoclonal structure. By contrast, we observed attenuated progression in cases characterized by high primary tumor heterogeneity, with metastatic competence acquired gradually and initial progression to solitary metastasis. Finally, we observed early divergence of primitive ancestral clones and protracted latency of up to two decades as a feature of pancreatic metastases.

Details

Database :
OAIster
Notes :
S.T. and H.X. are funded by Cancer Research UK (CRUK) (C50947/A18176). S.T., T.C., J.L., and M.G. are funded by the NIH Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital and Institute of Cancer Research (A109). J.I.L. is funded by the Ministerio de Economia y Competitividad (MINECO, SAF2016-79847-R). M.S., A.S., J.L., R.F., L.A., and L.S. are funded by the Royal Marsden Cancer Charity. K.L. is funded by UK Medical Research Council (MR/P014712/1). N.M. receives funding from CRUK, Rosetrees, and the NIHR BRC at University College London Hospitals. C.S is Royal Society Napier Research Professor. C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees and Stoneygate Trusts, NovoNordisk Foundation (ID 16584), the Breast Cancer Research Foundation (BCRF), the European Research Council (THESEUS), Marie Curie Network PloidyNet, the NIHR BRC at University College London Hospitals, and the CRUK University College London Experimental Cancer Medicine Centre. The work presented in this manuscript was funded by Cancer Research UK (grant reference number C50947/A18176), Ventana Medical Systems (grant reference numbers 10467 and 10530), the Kidney Cancer Fund of The Royal Marsden Cancer Charity, NIHR BRC at the Royal Marsden Hospital and Institute of Cancer Research (grant reference number A109), and the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202), and the Wellcome Trust (FC001202). In particular, we acknowledge the support of the Advanced Sequencing Facility and the High-Performance Computing at the Francis Crick Institute. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant number MR/L016311/1)., English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1080307149
Document Type :
Electronic Resource